Clots and bleeds: the outcomes of percutaneous coronary intervention in hemophilia patients with acute coronary syndrome
Patients with hemophilia undergoing PCI are at a significantly greater risk of adverse events, increased mortality, and longer hospital stays than the general population. To mitigate the risk of unfavorable outcomes, it is crucial to ensure adequate replenishment of coagulation factors and establish close collaboration between cardiologists and hematologists.
Authors
- Samer Asmar (ORCID: https://orcid.org/0000-0001-6385-6146)
- Georges Khattar (ORCID: https://orcid.org/0000-0003-1693-6746)
- Alexander Bershadskiy
- Ibrahim Al Saidi
- Fares Saliba
- Elie Bou Sanayeh (ORCID: https://orcid.org/0000-0002-6305-3797)
- Ghada Araji (ORCID: https://orcid.org/0000-0001-5339-3010)
- Michel Khoury (ORCID: https://orcid.org/0000-0003-2062-7428)
- Laurence Aoun (ORCID: https://orcid.org/0009-0007-4065-6636)
- Salman Khan (ORCID: https://orcid.org/0009-0004-3417-679X)
- Mitchell Weinberg
- Michel Al Achkar (ORCID: https://orcid.org/0000-0003-3015-0715)
Institutions
- Northwell Health (US)
- Staten Island University Hospital (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1002/ccd.31269
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00